» Authors » Luciana Ansaneli Naves

Luciana Ansaneli Naves

Explore the profile of Luciana Ansaneli Naves including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 304
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vilar L, Vilar C, Lyra R, Albuquerque L, Garrido A, Gadelha P, et al.
Arch Endocrinol Metab . 2024 Oct; 68:e230391. PMID: 39420933
Objective: Determining the etiology of hyperprolactinemia is fundamental for selecting the most appropriate treatment strategy. The aim of this study was to evaluate the usefulness and accuracy of prolactin levels...
2.
Bandeira de Santana L, de Souza Lima T, Costa A, Sandoval L, de Souza T, Mota L, et al.
Adv Rheumatol . 2024 Aug; 64(1):56. PMID: 39113135
Background: In the context of rheumatoid arthritis and its systemic inflammatory implications, there is an increasing interest in investigating the role of prolactin in the clinical and metabolic aspects of...
3.
Vilar L, Naves L, Martins M, Ribeiro-Oliveira Jr A
Best Pract Res Clin Endocrinol Metab . 2024 Mar; 38(3):101878. PMID: 38519400
A small proportion of the patients with acromegaly present with apparently normal basal GH levels and suppressible GH levels despite increased IGF-1 levels, a pattern called micromegaly by some authors....
4.
Dias A, Jacomo R, Nery L, Naves L
Clin Chim Acta . 2023 Dec; 552:117688. PMID: 38049046
Background And Objective: Recent guidelines classify low prolactin levels as low as <7 ng/mL and high levels as >25 ng/mL, while the "Homeostatically Functionally Increased Transient Prolactinemia" (HomeoFIT-PRL) range (25-100 ...
5.
Miranda I, Valadares L, Barra G, Mesquita P, Bandeira de Santana L, de Castro L, et al.
Front Endocrinol (Lausanne) . 2023 Mar; 14:1117873. PMID: 36967793
Objective: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome characterized by its clinical variability and complexity in diagnosis and treatment. We performed both clinical and molecular descriptions...
6.
Jacques J, Valadares L, Moura A, Oliveira M, Naves L
Front Endocrinol (Lausanne) . 2023 Mar; 14:1091185. PMID: 36875457
Objective: To describe the frequency of hypophysitis and hypopituitarism in cancer patients who are undergoing antineoplastic treatment with immunotherapy, as well as to describe the clinical, epidemiological, and demographic characteristics...
7.
Jardim-Santos G, Schulte H, Kurizky P, Gomes C, Nobrega O, de Gois E, et al.
Front Immunol . 2022 Dec; 13:1004023. PMID: 36451835
The present study applied distinct models of descriptive analysis to explore the integrative networks and the kinetic timeline of serum soluble mediators to select a set of systemic biomarkers applicable...
8.
Schulte H, Brito-Sousa J, Lacerda M, Naves L, de Gois E, Fernandes M, et al.
BMC Infect Dis . 2021 Aug; 21(1):727. PMID: 34332542
Background: Since the novel coronavirus disease outbreak, over 179.7 million people have been infected by SARS-CoV-2 worldwide, including the population living in dengue-endemic regions, particularly Latin America and Southeast Asia,...
9.
Garmes H, Boguszewski C, Miranda P, Martins M, da Silva S, Abucham Filho J, et al.
Arch Endocrinol Metab . 2021 Apr; 65(2):212-230. PMID: 33905631
Hypopituitarism is a disorder characterized by insufficient secretion of one or more pituitary hormones. New etiologies of hypopituitarism have been recently described, including head trauma, cerebral hemorrhage, and drug-induced hypophysitis....
10.
Naves L, Rosa I, de Souza Lima T, Bandeira de Santana L, de Castro L, Casulari L
Telemed J E Health . 2021 Apr; 27(8):905-914. PMID: 33877890
Telemedicine is a resource to provide health care to patients social distancing and prevent their exposure to the risk of contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...